Breast Enhancement Surgery: Procedures, Risks, Recovery, and Costs — Cost, Top Hospitals & Success Rates | MyMedicPlus

Breast enhancement surgery is an umbrella term for surgical procedures aimed at improving the appearance, size, shape, position, or proportion of the breasts. The three primary categories are breast augmentation (increasing volume with implants or fat transfer), mastopexy (breast lift to correct ptosis and restore youthful position), and combined augmentation mastopexy (addressing both volume and ptosis simultaneously). These procedures can also be combined with breast reduction to create symmetry, or performed as part of breast reconstruction after oncological surgery.

Breast enhancement is one of the most performed areas of cosmetic surgery globally, driven by both aesthetic desires and functional concerns such as asymmetry correction and post-pregnancy restoration. Pre-operative consultation involves a detailed breast examination, photographic documentation, measurement of breast dimensions (base width, nipple-to-fold distance, degree of ptosis), discussion of cup size goals, and imaging review where appropriate. Three-dimensional imaging systems (Vectra, Crisalix) allow virtual simulation of likely outcomes.

Procedures are performed under general anaesthesia at accredited surgical facilities by board-certified plastic surgeons. The treating surgeon's experience in breast surgery — including volume of cases, training in multiple techniques, and management of complications — is a critical quality indicator. Patients should review before-and-after photo galleries, understand the risks specific to each procedure, and have a frank consultation about their specific anatomical starting point and realistic achievable outcomes.

The 'mummy makeover' package combining breast enhancement (augmentation or lift) with abdominoplasty has grown in popularity, allowing women to address multiple post-pregnancy changes in a single anaesthetic. This approach reduces recovery time compared to two separate procedures but requires careful risk assessment given the longer operative time.

Breast augmentation addresses hypomastia (small breasts), breast asymmetry (bilateral size discrepancy), and post-partum or post-weight-loss volume deflation. Mastopexy (breast lift) corrects breast ptosis — sagging caused by pregnancy, breastfeeding, weight fluctuation, or natural ageing — where the nipple has descended below the inframammary fold (Grade III ptosis) or the nipple sits at or just below the fold level (Grade I-II ptosis). Ptosis without volume deficiency requires lift alone; volume deficiency with ptosis requires combined augmentation-mastopexy.

Congenital breast deformities including tuberous breast syndrome, Poland syndrome (absent pectoral muscle and breast), and severe asymmetry require specialised techniques beyond standard augmentation. Trans women seeking feminising breast surgery where hormone-induced breast development is insufficient typically undergo subpectoral augmentation — the procedure is the same as for cisgender women but may require additional planning given differences in chest wall anatomy. Breast enhancement may also include nipple-areola complex reduction or repositioning as a component of the aesthetic refinement.

Good candidates for breast enhancement are women (or trans women) who are in stable health, at a stable weight, non-smoking, with specific, realistic goals for improvement. Patients should understand that implants are not lifetime devices and may require future surgery, and that mastopexy scars are extensive though generally well-concealed. Women planning future pregnancies are counselled that augmentation and lift results may be affected by pregnancy and breastfeeding, and may consider deferring surgery until their family is complete.

Contraindications vary by procedure. Augmentation requires no undiagnosed breast pathology, adequate skin envelope for implant coverage, absence of connective tissue disorders that increase contracture risk, and age 18+ (silicone 22+ per FDA). Mastopexy requires excellent general health and wound healing capacity; smokers are at high risk of nipple-areola complex necrosis from the combined tension on the blood supply and are required to stop six weeks before and after surgery. Patients with a strong family history of breast cancer should complete genetic counselling and consider their individual screening protocol alongside the timing of breast enhancement surgery.

Breast augmentation for enhancement uses silicone cohesive gel implants (fifth generation round smooth or shaped) in a dual-plane pocket via an inframammary or periareolar incision — the combination offering the most predictable, aesthetically pleasing result. Fat transfer augmentation provides up to one cup size increase using the patient's own harvested fat, avoiding all implant risks but requiring sufficient donor fat and accepting a less predictable augmentation volume due to variable fat reabsorption.

Mastopexy techniques are classified by incision pattern based on degree of ptosis correction required: the Benelli (periareolar) lift corrects mild ptosis with a scar only around the areola; the vertical (lollipop) lift adds a vertical scar from areola to inframammary fold for moderate ptosis; and the Wise pattern (anchor/inverted T) adds a horizontal scar along the inframammary fold for severe ptosis — this also addresses skin excess in both horizontal and vertical dimensions. Combined augmentation mastopexy requires careful planning as the augmenting implant adds tension to the lifted tissue blood supply; some surgeons prefer staging these procedures 3-6 months apart rather than combining them, particularly when significant ptosis correction is needed.

The operating surgeon reviews the patient's complete medical history, current medications, and desired outcomes before finalising the surgical plan. Preoperative digital photography and computer simulation allow the surgeon and patient to align expectations and visualise potential results. Anaesthetic choice — general anaesthesia or intravenous sedation with local anaesthesia — is decided in consultation with the anaesthesiologist based on procedure complexity, patient health status, and patient preference. Postoperative care instructions, including wound care, activity restrictions, and follow-up scheduling, are provided in written form before surgery.

Breast enhancement procedures consistently generate among the highest patient satisfaction rates in plastic surgery. BREAST-Q validated outcome data demonstrate significant improvements in psychosocial wellbeing, sexual wellbeing, chest satisfaction, and physical wellbeing at three and five years post-operatively. Women report feeling more feminine, more confident in clothing and swimwear, and more satisfied with their overall body image. For women with symptomatic ptosis (skin fold under the breast causing intertrigo, bra strap discomfort), mastopexy provides functional as well as aesthetic benefit.

Breast symmetry correction — whether through differential implant sizing or contralateral breast reduction with augmentation of the smaller side — has a profound positive effect on body image and the ability to wear fitted clothing. For trans women, breast enhancement surgery is one of the most impactful gender-affirming procedures, with multiple studies demonstrating significant improvements in gender dysphoria, quality of life, and mental health outcomes. Realistic expectations, high-quality surgeon selection, and appropriate recovery period all contribute to optimal outcomes.

Breast enhancement surgery carries procedure-specific and general surgical risks. Augmentation risks include capsular contracture (5-15% at 10 years), implant rupture (10% at 10 years for silicone), asymmetry requiring revision (10-15%), BIA-ALCL with textured implants (rare), altered nipple sensation, and breast implant illness symptoms. Mastopexy risks include extensive scarring, wound dehiscence (particularly at the T-junction of anchor scars), partial or total nipple-areola complex necrosis (rare — most common in smokers, diabetics, or patients with very long nipple-to-fold distances requiring aggressive elevation), and asymmetry.

Combined augmentation mastopexy carries higher complication rates than either procedure performed alone — wound healing complications, particularly at the T-junction, occur in 5-15% of cases due to competing tissue tension from the implant and the tightened skin envelope. Haematoma and seroma are general surgical risks. DVT risk is low for short procedures but increases with longer combined operations; sequential compression devices and appropriate mobilisation are standard. All breast surgery patients should be aware that future breast cancer screening by mammography is somewhat more technically challenging (though not prevented) with implants in situ.

Recovery from augmentation alone is typically 1-2 weeks to desk work, with exercise restriction for 4-6 weeks. Mastopexy recovery is similar but requires careful wound surveillance — dressings and micropore tape are applied to incisions for 3-6 weeks to support the healing scars. Combined procedures require 2-3 weeks before light work and 6-8 weeks before strenuous exercise. A supportive surgical bra without underwire is worn for 4-6 weeks.

Implant surveillance using MRI is recommended by the FDA at 5-6 years for silicone implants and then every 2-3 years to detect silent rupture. Scar management with silicone gel, vitamin E oil, and sun protection significantly improves mastopexy scar appearance over 12-18 months. Patients should perform monthly breast self-examination and maintain annual clinical breast examination with their GP or gynaecologist. Late-onset seroma appearing months after augmentation should prompt urgent evaluation for BIA-ALCL. Annual plastic surgery follow-up is recommended.

In the USA, breast augmentation costs USD 6,000-12,000 and mastopexy USD 8,000-14,000; combined augmentation mastopexy USD 10,000-18,000. UK private costs are GBP 4,500-10,000 for augmentation and GBP 6,000-12,000 for combined procedures. The complexity of combined augmentation mastopexy justifies higher surgeon fees. Mummy makeover packages (combining breast and abdominal procedures) in the USA cost USD 18,000-30,000.

Turkey is the leading destination for breast enhancement medical tourism, with all-inclusive augmentation packages at USD 3,000-5,500 and combined augmentation mastopexy at USD 5,000-8,000 — savings of 40-65% versus UK prices. Thailand offers USD 4,000-7,000 for augmentation at internationally accredited hospitals. India provides USD 2,000-4,000 for breast augmentation. Medical tourists should budget for flights, accommodation during recovery (minimum 7-10 days), and follow-up care at home. MyMedicPlus coordinates personalised quotes from JCI-accredited breast surgery centres globally.

Non-surgical breast enhancement options are limited in effect compared to surgery. Padded bras, breast inserts, and compression garments improve perceived breast size and shape without any risk. For mild ptosis, push-up bras provide effective lifting without surgery. Non-surgical 'Brazilian breast lift' using radiofrequency or ultrasound tightening provides modest skin tightening but cannot correct significant ptosis. Autologous fat transfer provides a natural option for modest augmentation (half to one cup size) without implant risks, though results are less predictable and repeat sessions may be required.

For women concerned about implant risks but desiring significant augmentation, macrotextured implants can be avoided in favour of smooth round implants to minimise BIA-ALCL risk, while still achieving excellent volume increase. Explantation with or without replacement is an option for women who develop breast implant illness symptoms or wish to remove implants — mastopexy at the time of explantation restores breast shape when implants are removed.